You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
ETHYLENE GLYCOL |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB2246 Geisinger Epic ID: 54549 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Serum or plasma. | |
Preferred collection container: |
||
Alternate Collection Container: |
3.5 mL gold-top (serum separator) tube
3 mL green/yellow-top (plasma separator) tube
|
|
Specimen required: |
Minimum 2.0 mL serum or plasma; minimum 1 mL. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow to serum clot. Centrifuge to separate serum or plasma within 2 hours of collection. Remove serum from cells. | |
Transport temperature: |
Refrigerated (preferred) or room temperature. | |
Specimen stability: |
Room temperature or refrigerated: 3 days. | |
Rejection criteria: |
Stability limits exceeded. | |
TEST DETAILS |
||
Reference interval: |
Negative. Cutoff concentration ethylene glycol: 10 mg/dL |
|
Additional information: |
For 5% of patients with history of chronic alcohol consumption, elevated result between 10 and 35 mg/dL may be expected due to high concentration of 2,3-butanediol. Propylene glycol is a known compound that interferes with this assay. Laboratory will notify the ordering provider if propylene glycol interference is suspected. | |
CPT code(s): |
82693 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Serum ethylene glycol. | |
Methodology: |
Enzymatic |
|
Synonyms: |
ETHGLY
|
|
Clinical significance: |
Ethylene glycol screen is used to evaluate and monitor ethylene glycol toxicity. Ingestion of ethylene glycol can result in central nervous system depression (0.5-12 hrs. post ingestion), cardiopulmonary compromise (12-36 hrs. post ingestion) and renal insufficiency (24-72 hrs. post ingestion) from toxic metabolites. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/29/2022 | |